Furthermore we were able to show that the antibody against 14-3-3, which is down-regulated in glaucoma patients (p < 0.01) (see Additional file 1: Figure S1), has protective effects on stressed neuroretinal cells, documented by an increased viability and reduced ROS-level of the cells. This evidence concerns the gene YWHAQ and glaucoma.